Base task order funding; to A15 award; 1700028I sigmovir biosystems, INC.;RDB--10; IID can 8470036 $591,222

Ended Awarded Last action

Contract number
75N93018F00002
Awardee
Awarding agency
Obligated
$949,831

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 100% obligated
$949,831.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00004 · Purpose: to DE-obligate remaining funds and administratively close the task order. -$4,509
Funding Only Action P00003 · Purpose: to DE-obligate funds from FY18. -$9,935
Exercise an Option P00002 · Purpose: to exercise quantity options 1, 1C, and 1D in the combined amount of $373,053 and extend the completion date through july 29, 2020. $373,053
Change Order P00001 · Purpose: to issue a change order revising the statement of work and to mutually agree upon a $0.00 equitable adjustment. $0
Original award $591,222

About this award

Written by GovTribe AI ·

Sigmovir Biosystems, Inc. was awarded a $591,222 cost-plus-fixed-fee delivery order against the National Institute of Allergy and Infectious Diseases' (NIAID) Preclinical Models of Infectious Diseases master IDIQ contract for the period 2017 to 2024. The delivery order, set to be completed by September 2023, provides base task order funding under award number 1700028I in support of NIAID's pre-clinical models of infectious diseases program. Specifically, Sigmovir Biosystems will utilize the nearly $600,000 in initial funding to further the development and application of pre-clinical disease models, aiding NIAID's infectious disease research efforts. The total potential value of the delivery order is $949,831. Performance will take place in Potomac, Maryland. No set-aside designation was applied to this award.

Quick answers

Who was awarded contract 75N93018F00002?

75N93018F00002 was awarded to Sigmovir Biosystems, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 27, 2018.

How much is contract 75N93018F00002 worth?

The government has obligated $949,831 on 75N93018F00002.

Is contract 75N93018F00002 an order under another contract?

Yes. 75N93018F00002 is a delivery order under HHSN272201700028I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract 75N93018F00002 competed?

The extent of competition for 75N93018F00002 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login